Cencora | Pharma solutions Revenue and Competitors
Estimated Revenue & Valuation
- Cencora | Pharma solutions's estimated annual revenue is currently $552.3M per year.
- Cencora | Pharma solutions's estimated revenue per employee is $201,000
Employee Data
- Cencora | Pharma solutions has 2748 Employees.
- Cencora | Pharma solutions grew their employee count by -2% last year.
Cencora | Pharma solutions's People
Name | Title | Email/Phone |
---|
Cencora | Pharma solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Cencora | Pharma solutions?
At Cencora, we are investing and innovating alongside our pharma customers to unlock their product’s potential. Cencora is a leading global pharmaceutical solutions organization centered on improving lives. We partner with pharmaceutical innovators and care providers to facilitate access to pharmaceuticals and healthcare products. Our pharma solutions — ranging from support during drug discovery to lifecycle management — help pharmaceutical and biopharma companies of all sizes reach full product potential. Previously known as AmerisourceBergen, our 46,000+ Cencora team members power our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue.
keywords:N/AN/A
Total Funding
2748
Number of Employees
$552.3M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $810.9M | 2758 | 0% | N/A |
#2 | $428.7M | 2766 | 2% | N/A |
#3 | $561.7M | 2767 | -1% | N/A |
#4 | $886.4M | 2777 | N/A | N/A |
#5 | $300M | 2797 | 13% | N/A |